Revision as of 10:06, 6 August 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (changes to verified fields - updated 'ChemSpiderID_Ref', 'DrugBank_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per [[Misplaced Pages:WikiProject Chemicals/Chembox validation|Chem/Drugbox validation← Previous edit | Revision as of 00:21, 13 August 2011 edit undoCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChemSpiderID_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per Chem/Drugbox validationNext edit → | ||
Line 2: | Line 2: | ||
{{drugbox | {{drugbox | ||
⚫ | | UNII_Ref = {{fdacite|correct|FDA}} | ||
| Verifiedfields = changed | |||
⚫ | | UNII_Ref = {{fdacite| |
||
| UNII = TZ4OX61974 | | UNII = TZ4OX61974 | ||
| verifiedrevid = |
| verifiedrevid = 443322535 | ||
| IUPAC_name = 3--''N''-hydroxy-''N''-methylpropanamide | | IUPAC_name = 3--''N''-hydroxy-''N''-methylpropanamide | ||
| image = Tepoxalin.png | | image = Tepoxalin.png |
Revision as of 00:21, 13 August 2011
"Zubrin" redirects here. For the aerospace engineer, see Robert Zubrin. Pharmaceutical compoundClinical data | |
---|---|
Routes of administration | Oral |
ATCvet code | |
Legal status | |
Legal status |
|
Identifiers | |
IUPAC name
| |
PubChem CID | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.166.553 |
Chemical and physical data | |
Formula | C20H20ClN3O3 |
Molar mass | 385.844 g/mol g·mol |
(verify) |
Tepoxalin is a nonsteroidal anti-inflammatory drug approved for veterinary use (in dogs) in the United States and the European Union. It is primarily used to reduce inflammation and relief of pain caused by musculoskeletal disorders such as hip dysplasia and arthritis.
It is generally marketed under the brand name Zubrin.
References
This veterinary medicine–related article is a stub. You can help Misplaced Pages by expanding it. |